Proffitt & Goodson’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $702K | Buy |
1,833
+19
| +1% | +$7.28K | 0.11% | 76 |
|
|
2025
Q1 | $627K | Hold |
1,814
| – | – | 0.1% | 76 |
|
|
2024
Q4 | $544K | Sell |
1,814
-25
| -1% | -$7.5K | 0.09% | 81 |
|
|
2024
Q3 | $747K | Sell |
1,839
-33
| -2% | -$13.4K | 0.12% | 74 |
|
|
2024
Q2 | $601K | Buy |
1,872
+5
| +0.3% | +$1.61K | 0.11% | 77 |
|
|
2024
Q1 | $623K | Sell |
1,867
-723
| -28% | -$241K | 0.11% | 78 |
|
|
2023
Q4 | $701K | Sell |
2,590
-13
| -0.5% | -$3.52K | 0.13% | 74 |
|
|
2023
Q3 | $640K | Sell |
2,603
-4
| -0.2% | -$984 | 0.13% | 74 |
|
|
2023
Q2 | $791K | Sell |
2,607
-72
| -3% | -$21.9K | 0.16% | 68 |
|
|
2023
Q1 | $706K | Buy |
2,679
+12
| +0.4% | +$3.16K | 0.14% | 71 |
|
|
2022
Q4 | $640K | Buy |
2,667
+11
| +0.4% | +$2.64K | 0.14% | 73 |
|
|
2022
Q3 | $488K | Buy |
2,656
+110
| +4% | +$20.2K | 0.11% | 78 |
|
|
2022
Q2 | $428K | Buy |
2,546
+154
| +6% | +$25.9K | 0.09% | 83 |
|
|
2022
Q1 | $599K | Sell |
2,392
-275
| -10% | -$68.9K | 0.11% | 78 |
|
|
2021
Q4 | $685K | Buy |
2,667
+270
| +11% | +$69.3K | 0.12% | 76 |
|
|
2021
Q3 | $582K | Sell |
2,397
-80
| -3% | -$19.4K | 0.11% | 73 |
|
|
2021
Q2 | $512K | Sell |
2,477
-52
| -2% | -$10.7K | 0.09% | 77 |
|
|
2021
Q1 | $476K | Buy |
2,529
+71
| +3% | +$13.4K | 0.09% | 78 |
|
|
2020
Q4 | $404K | Sell |
2,458
-67
| -3% | -$11K | 0.08% | 81 |
|
|
2020
Q3 | $315K | Buy |
2,525
+232
| +10% | +$28.9K | 0.07% | 81 |
|
|
2020
Q2 | $223K | Sell |
2,293
-971
| -30% | -$94.4K | 0.05% | 83 |
|
|
2020
Q1 | $293K | Sell |
3,264
-272
| -8% | -$24.4K | 0.08% | 73 |
|
|
2019
Q4 | $523K | Buy |
3,536
+5
| +0.1% | +$740 | 0.12% | 71 |
|
|
2019
Q3 | $425K | Sell |
3,531
-22
| -0.6% | -$2.65K | 0.1% | 72 |
|
|
2019
Q2 | $480K | Sell |
3,553
-8
| -0.2% | -$1.08K | 0.12% | 70 |
|
|
2019
Q1 | $464K | Buy |
3,561
+3,543
| +19,683% | +$462K | 0.12% | 68 |
|
|
2018
Q4 | $2K | Buy |
+18
| New | +$2K | ﹤0.01% | 161 |
|